Shunichi Koriyama

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Clinical and molecular characteristics of thalamic gliomas in adults: prognostic impact of TERT promoter mutation.

Clinical and molecular characteristics of thalamic gliomas in adults: prognostic impact of TERT promoter mutation.

Journal: Neurosurgical review
Published: March 14, 2026

Analysis of PTPRZ expression in glioma and schwannoma - PTPRZ-long is highly expressed and shed in glioma.

Analysis of PTPRZ expression in glioma and schwannoma - PTPRZ-long is highly expressed and shed in glioma.

Journal: Biochemical and biophysical research communications
Published: October 28, 2025

Cerebrospinal fluid soluble protein tyrosine phosphatase receptor type Z detected with human natural killer-1 antibody as a practical biomarker for glioma diagnosis.

Cerebrospinal fluid soluble protein tyrosine phosphatase receptor type Z detected with human natural killer-1 antibody as a practical biomarker for glioma diagnosis.

Journal: Neuro-oncology advances
Published: September 19, 2025

Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas.

Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas.

Journal: Neuro-oncology
Published: July 17, 2025

High-precision intraoperative diagnosis of gliomas: integrating imaging and intraoperative flow cytometry with machine learning.

High-precision intraoperative diagnosis of gliomas: integrating imaging and intraoperative flow cytometry with machine learning.

Journal: Frontiers in neurology
Published: June 14, 2025

Severity of Clinical Symptoms of Supplementary Motor Area Syndrome Correlates with the Extent of Tumor Resection in the Brain.

Severity of Clinical Symptoms of Supplementary Motor Area Syndrome Correlates with the Extent of Tumor Resection in the Brain.

Journal: Neurologia medico-chirurgica
Published: February 09, 2025

Association between autologous formalin-fixed tumor vaccine (AFTV) therapy, molecular pathological markers, and survival outcomes in glioblastoma.

Association between autologous formalin-fixed tumor vaccine (AFTV) therapy, molecular pathological markers, and survival outcomes in glioblastoma.

Journal: Brain tumor pathology
Published: January 31, 2025

"Apathetic look" is a valuable indicator of intraoperative supplementary motor area syndrome during awake craniotomy.

"Apathetic look" is a valuable indicator of intraoperative supplementary motor area syndrome during awake craniotomy.

Journal: Neurosurgical review
Published: July 29, 2024

Association Between Pretreatment 11C-Methionine Positron Emission Tomography Metrics, Histology, and Prognosis in 125 Newly Diagnosed Patients with Adult-Type Diffuse Glioma Based on the World Health Organization 2021Classification.

Association Between Pretreatment 11C-Methionine Positron Emission Tomography Metrics, Histology, and Prognosis in 125 Newly Diagnosed Patients with Adult-Type Diffuse Glioma Based on the World Health Organization 2021Classification.

Journal: World neurosurgery
Published: March 05, 2024

Information-guided Surgery Centered on Intraoperative Magnetic Resonance Imaging Guarantees Surgical Safety with Low Mortality.

Information-guided Surgery Centered on Intraoperative Magnetic Resonance Imaging Guarantees Surgical Safety with Low Mortality.

Journal: Neurologia medico-chirurgica
Published: January 10, 2024

Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma.

Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma.

Journal: Neurosurgical review
Published: June 11, 2023

Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas.

Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas.

Journal: Journal of neuro-oncology
Published: November 30, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026